Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Chemokine CXCR3 receptor inhibitors emerge from Celltech R&D

March 30, 2005

Complement inhibitors for neurodegenerative, autoimmune disorders disclosed in recent patents

March 30, 2005

New treatments for respiratory disorders described in patent literature

March 30, 2005

Immunosuppressant agents reported by Poseidon Pharmaceuticals

March 30, 2005

New treatments for obesity described in patent literature

March 24, 2005

Patents covering treatments for pain disclosed

March 24, 2005

Roche reports agents for the treatment of diabetes

March 24, 2005

Antibacterial oxazolidinones described in a patent

March 23, 2005

AstraZeneca discloses JNK3 inhibitors

March 23, 2005

New treatments for psychotic disorders described in patent literature

March 23, 2005

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026